MX2011010191A - Peptidos c6orf167 y vacunas que continen los mismos. - Google Patents

Peptidos c6orf167 y vacunas que continen los mismos.

Info

Publication number
MX2011010191A
MX2011010191A MX2011010191A MX2011010191A MX2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A MX 2011010191 A MX2011010191 A MX 2011010191A
Authority
MX
Mexico
Prior art keywords
peptides
c6orf167
methods
antigen
inducing
Prior art date
Application number
MX2011010191A
Other languages
English (en)
Spanish (es)
Inventor
Yusuke Nakamura
Ryuji Ohsawa
Takuya Tsunoda
Sachiko Yoshimura
Tomohisa Watanabe
Yataro Daigo
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of MX2011010191A publication Critical patent/MX2011010191A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
MX2011010191A 2009-04-01 2010-03-31 Peptidos c6orf167 y vacunas que continen los mismos. MX2011010191A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21170009P 2009-04-01 2009-04-01
PCT/JP2010/002352 WO2010113495A1 (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
MX2011010191A true MX2011010191A (es) 2011-11-29

Family

ID=42827803

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010191A MX2011010191A (es) 2009-04-01 2010-03-31 Peptidos c6orf167 y vacunas que continen los mismos.

Country Status (14)

Country Link
US (1) US20120128705A1 (enExample)
EP (1) EP2414383A4 (enExample)
JP (1) JP5728759B2 (enExample)
KR (1) KR20120034605A (enExample)
CN (2) CN102448980B (enExample)
AU (1) AU2010231381A1 (enExample)
BR (1) BRPI1013384A2 (enExample)
CA (1) CA2757210A1 (enExample)
IL (1) IL215268A0 (enExample)
MX (1) MX2011010191A (enExample)
RU (1) RU2011144088A (enExample)
SG (2) SG2014011423A (enExample)
TW (1) TW201100090A (enExample)
WO (1) WO2010113495A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013671A2 (en) 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
CN102884190B (zh) 2010-03-11 2016-03-23 肿瘤疗法科学股份有限公司 Hjurp肽及包含它们的疫苗
JP2013542711A (ja) * 2010-08-19 2013-11-28 オンコセラピー・サイエンス株式会社 がんの治療および診断の標的遺伝子としてのC6orf167

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1273499A (en) * 1997-10-24 1999-05-17 Human Genome Sciences, Inc. 148 human secreted proteins
CN1351069A (zh) * 2000-10-26 2002-05-29 上海博德基因开发有限公司 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
CN101139392B (zh) * 2002-09-12 2012-12-26 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
DK2325306T3 (en) * 2005-02-25 2014-03-03 Oncotherapy Science Inc Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
WO2007013671A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
EP2295571A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
JP5409658B2 (ja) * 2008-03-13 2014-02-05 セレラ コーポレーション 静脈血栓症に関連した遺伝子多型、その検出方法および使用

Also Published As

Publication number Publication date
WO2010113495A1 (en) 2010-10-07
SG174998A1 (en) 2011-11-28
EP2414383A4 (en) 2013-07-31
TW201100090A (en) 2011-01-01
EP2414383A1 (en) 2012-02-08
CN104774260A (zh) 2015-07-15
BRPI1013384A2 (pt) 2016-03-29
CA2757210A1 (en) 2010-10-07
US20120128705A1 (en) 2012-05-24
CN102448980A (zh) 2012-05-09
RU2011144088A (ru) 2013-05-10
JP5728759B2 (ja) 2015-06-03
KR20120034605A (ko) 2012-04-12
AU2010231381A1 (en) 2011-11-03
CN102448980B (zh) 2015-04-15
JP2012522488A (ja) 2012-09-27
IL215268A0 (en) 2011-11-30
SG2014011423A (en) 2014-05-29

Similar Documents

Publication Publication Date Title
MX2010014044A (es) Peptidos de epitope cdca1 y vacunas que contienen los mismos.
PH12019502194A1 (en) Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
GB201004575D0 (en) Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
MX362912B (es) Péptidos ube2t y vacunas que incluyen los mismos.
BR112015021828A2 (pt) Peptídeos de kntc2 e vacinas que contêm os mesmos
CR20210464A (es) Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido en carcinoma del pulmón amicrocítico (nsclc)
WO2019197567A3 (en) Antigenic peptides for prevention and treatment of cancer
MX2011012013A (es) Peptidos ttk y vacunas que incluyen los mismos.
MX337756B (es) Peptido de epitope hig2 y urlc10 y vacunas que contienen el mismo.
PH12014500720A1 (en) Topk peptides and vaccines including the same
MX2011010191A (es) Peptidos c6orf167 y vacunas que continen los mismos.
MX2012008657A (es) Peptidos melk modificados y vacunas que contienen los mismos.
EP4219525A3 (en) Foxm1-derived peptide, and vaccine including same
MX2022006022A (es) Peptido derivado de depdc1 y vacuna que lo contiene.
MX2015007015A (es) Peptidos sema5b y vacunas que contienen los mismos.
EP4353321A3 (en) Koc1-derived peptide and vaccine including same
BR112013005448A2 (pt) peptídeos de ttll4 e vacinas contendo os mesmos.
EP3848383A3 (en) Urlc10-derived peptide and vaccine containing same
SG10201900879PA (en) Cdca1-derived peptide and vaccine containing same
BR112012013371A2 (pt) peptídeo mybl2 e vacinas contendo os mesmos.
EP2513136A4 (en) PEPTIDES TMEM22 AND VACCINES COMPRISING THEM
MX344579B (es) Peptidos hjurp y vacunas que incluyen los mismos.
MX2012011666A (es) Peptidos cluap1 y vacunas que incluyen los mismos.
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc

Legal Events

Date Code Title Description
FG Grant or registration